Monderma

Monderma: prescription skincare led by a GPhC-registered pharmacy

Monderma is a UK-based online skincare service that combines dermatologist oversight with a registered pharmacy operation. Customers begin with a free online consultation, share the skin concern they most want to address, and are then prescribed a nightly treatment tailored to that concern. The service is built around prescription-strength actives rather than over-the-counter cosmetics, and the company states that its pharmacy team is registered with the General Pharmaceutical Council (GPhC).

The site presents the model as a three-step process: describing the concern, starting a personalised nightly treatment, and adjusting strengths as the skin responds. Progress is described as clinically assessed at each stage, with the company claiming visible difference from week one and ongoing progress across twelve weeks.

Conditions covered by the treatment range

Monderma organises its offering around four skin concerns, each with its own treatment pathway:

• Hyperpigmentation — aimed at more even-looking skin tone, dark spots, sun damage and melasma, including signs of sun spots, melasma and injury-related pigmentation.
• Wrinkles — directed at fine lines, dull skin and loss of elasticity, with the goal of a smoother, plumper complexion and improved look of firmness and volume.
• Acne — addresses hormonal congestion, blackheads, pimples and pitting.
• Rosacea — intended to calm visible flare-ups, redness, warmth and sensitivity.

For all four pathways, the site states that visible changes are often seen in 8–12 weeks.

The active ingredients behind the formulations

The range draws on a defined list of prescription and clinical actives, each given its own page on the site: tretinoin, adapalene, clindamycin, ivermectin, hydroquinone, tranexamic acid, azelaic acid, niacinamide and ectoine. The company describes its core offering as a retinoid cream combining three actives in a single product, and contrasts it with high-street retinol, which it characterises as slower, more surface-level, requiring multiple products and offering limited change. Monderma attributes to its own retinoid formulation up to 20× greater efficacy and faster visible results, claims that reflect the company's own presentation rather than an independent assessment.

Consultation, prescribing and pharmacy oversight

Access to treatment is conditional on an online dermatological consultation, and the company notes that orders are subject to that consultation. The clinical team is named on the site: Dr Amandeep Dhillon holds the role of Superintendent Pharmacist (GPhC 2063921), Anand Vadgama is listed as Lead Prescriber (GPhC 2064587), Ridhi Patel as Senior Pharmacist (GPhC 2071754) and Geeta Kumar as Lead Technician (GPhC 5103231). Dr Bernard Ho, MBBS, FRCP (Dermatology), GMC 7403089, is identified as Medical Director. The pharmacy itself operates under GPhC number 9012305.

The company also states that it works with MHRA-approved suppliers and describes itself as trusted by thousands across the UK. A 12-week money-back guarantee applies to its treatments.

Pricing and subscription terms

At the time of writing this profile, the site advertised a first order at £23.99 reduced to £17.99, with the standard entry price given as £23.99. The company indicates that customers can cancel or restart at any time, and that the offer is subject to the online dermatological consultation.

Company details and operating addresses

Monderma is registered under company number 14567976, with VAT number GB445540693. Its registered address is International House, 6 South Molton Street, London W1K 5QF, while the trading and pharmacy address is Unit 2C Gazelle Buildings, Wallingford Road, Uxbridge UB8 2RW. The site also references a referral programme offering £20 to customers who refer a friend.